2022 SCHEDULE

For more information on each program topic, see the Learning Objectives.

THURSDAY, MARCH 24 - PHARMACOLOGY PRECONFERENCE AND GENERAL SESSIONS
Pharmacology Preconference may be attended as a stand-alone event.
7:30 AMBreakfast and Commercial Event sponsored by Janssen - Xarelto
8:45 AMWelcome to Pharmacology Preconference
9:00 AMPrevention and Treatment of COVID-19: A Review of the Current Data
Ty Gluckman MD, FACC
9:50 AMBeverage Break
10:05AMContraception, Hormone Replacement Therapy and Cardiovascular Disease
Pam Morris, MD, FACC, FAHA, FASPC, FNLA
10:55 AMSupplement Use in Cardiovascular Patients: What You Need to Know
Rhonda Cooper-Dehoff, PharmD
11:45 PMStretch Break
12:00 PMLunch and Commercial Event: Recurrent Pericarditis Sponsored by Kiniksa
1:00 PMHeart Failure: Evidenced-based Pharmacologic Therapies
Kimberly Cuomo, RN, MSN, CRNP, CHFN
1:50 PMImpacts of SGLT2s and GLP1s on CVD, Diabetes, and Renal Function
Eryn Bryant, MSN, NP-C and SUn Kim, MD, MS
2:40 PMExhibit Hall Open and Beverage Break
3:30 PMWelcome to General Sessions
3:45 PMOpening and Honorary Fellow Keynote: Assessing Cardiovascular Risk: Where are the Data Now and Where Do We Go From Here?
Donald Lloyd-Jones, MD, ScM, FACC, FAHA
4:45 PMSpectrum of CKD and the Impact on Overall Cardiovascular Health
Glenn Chertow, MD, MPH
5:30 PMOpening Reception in the Exhibit Hall with Poster Presentations in the Exhibit Hall
7:00 PMDinner and Commercial Event
FRIDAY, MARCH 25 - GENERAL SESSIONS
7:30 AMBreakfast Program
8:30 AMActivity Break
8:50 AMKeynote: Resistant Hypertension: Who is at risk? Detection, Evaluation and Treatment
Vivek Bhalla, MD
9:40 AMCOVID-19 Long-Haulers: The search for answers
10:15 AMOral Abstract Presentations
10:45 AMExhibit Hall and Beverage Break
11:30 AMManagement of Atrial Fibrillation, from A to Z
Bill Miles, MD
12:15 PMLunch and Commercial Event
Add on Efficacy. Oral, Nonstatin Therapies for Lowering LDL-C
Sponsored by: Esperion
1:15 PMExhibit Hall Break
2:15 PMMaternal Mortality, Cardiovascular Disease and Prevention
Erin Ferranti, PhD, MPH, RN, FAHA
Ki Park MD, MS, FACC
3:10 PMConcurrent Sessions (pick one)
Handheld Echo, New Technology, New Skills for Nurses
Cecilia Tagle-Cornell, APRN, ACNP-BC
PCNA Tools to Engage and Motivate Patients to Heart Healthy Lifestyle
Kim Newlin, RN, MS
Heather Harker Ryan, RN, MS
Essential Skills for Today's Nurse Leaders: Making an Impact with Social Media
Lynne Braun, RN, PhD
4:10 PMBeverage Break
4:45 PMConcurrent sessions (pick one)
Handheld Echo, New Technology, New Skills for Nurses
Behavior Change Principles in Action: PCNA Tools to Engage and Motivate Patients to Heart Healhty Lifestyle
Kim Newlin, RN, MS
Heather Harker Ryan, RN, MS
Essential Skills for Today's Nurse Leaders: Making an Impact with Social Media
Lynne Braun, RN, PhD
5:30 PMWine Reception
5:45 PMComplex Cases in Lipid Management: Treating LDL and Beyond
Susan Halli-Demeter DNP, CNP, FNP-BC
SATURDAY, MARCH 26 - GENERAL SESSIONS
7:30 AMBreakfast Program Sponsored by BMS and Pfizer - CVD and Oncology Links 2021-2022
PCNA and International CardioOncology Society, North America (non-CE)
8:30 AMAwards Ceremony
8:50 AMKeynote: Cardiovascular Health and CVD Risk in LGBTQI+ Populations
Billy Caceres, PhD, RN, FAHA, FAAN
9:50 AMActivity and Beverage Break
10:10 AMPrecision Medicine and Genetics: Implications for CVD Prevention and Management
Carolyn Yung Ho
10:50 AMClosing Keynote: Posttraumatic Growth: Renewing your health and well-being following the COVID-19 pandemic
Tim Cunningham, RN, DrPH, FAAN
11:55 AMPrize Drawing and Closing

ACCREDITATION STATEMENT

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.